JP6660372B2 - 送達システム - Google Patents

送達システム Download PDF

Info

Publication number
JP6660372B2
JP6660372B2 JP2017505805A JP2017505805A JP6660372B2 JP 6660372 B2 JP6660372 B2 JP 6660372B2 JP 2017505805 A JP2017505805 A JP 2017505805A JP 2017505805 A JP2017505805 A JP 2017505805A JP 6660372 B2 JP6660372 B2 JP 6660372B2
Authority
JP
Japan
Prior art keywords
delivery vehicle
lipid
digestible
active ingredient
lipophilic active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2017505805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017532291A5 (https=
JP2017532291A (ja
Inventor
ティモシー ジェームズ ウスター，
ティモシー ジェームズ ウスター，
ローレンス ドナートケープル，
ローレンス ドナートケープル，
アンウェシャ サルカール，
アンウェシャ サルカール，
シモネ アキタプエース，
シモネ アキタプエース，
Original Assignee
ソシエテ・デ・プロデュイ・ネスレ・エス・アー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ソシエテ・デ・プロデュイ・ネスレ・エス・アー filed Critical ソシエテ・デ・プロデュイ・ネスレ・エス・アー
Publication of JP2017532291A publication Critical patent/JP2017532291A/ja
Publication of JP2017532291A5 publication Critical patent/JP2017532291A5/ja
Application granted granted Critical
Publication of JP6660372B2 publication Critical patent/JP6660372B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2017505805A 2014-08-07 2015-07-27 送達システム Expired - Fee Related JP6660372B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14180139 2014-08-07
EP14180139.9 2014-08-07
PCT/EP2015/067123 WO2016020217A1 (en) 2014-08-07 2015-07-27 A delivery system

Publications (3)

Publication Number Publication Date
JP2017532291A JP2017532291A (ja) 2017-11-02
JP2017532291A5 JP2017532291A5 (https=) 2019-06-27
JP6660372B2 true JP6660372B2 (ja) 2020-03-11

Family

ID=51302903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017505805A Expired - Fee Related JP6660372B2 (ja) 2014-08-07 2015-07-27 送達システム

Country Status (5)

Country Link
US (2) US10052287B2 (https=)
EP (1) EP3177274A1 (https=)
JP (1) JP6660372B2 (https=)
CN (1) CN106572979B (https=)
WO (1) WO2016020217A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011239414A1 (en) 2010-04-15 2012-11-08 The Washington University Prodrug compositions, prodrug nanoparticles, and methods of use thereof
CN107019797B (zh) * 2016-01-30 2020-07-03 天津赫莱恩特生物科技有限公司 一种提高球虫卵囊穿透细胞能力的组合物及其制备方法
FR3054104B1 (fr) * 2016-07-19 2018-08-31 Galewpet Support pour l’absorption orale d’une substance active par des animaux, son procede de preparation et ses utilisations
WO2019066442A2 (ko) * 2017-09-27 2019-04-04 한양대학교 산학협력단 제2형 당뇨병 치료를 위한 락토페린 기반의 유전자 전달체
KR102144380B1 (ko) 2017-09-27 2020-08-13 한양대학교 산학협력단 제2형 당뇨병 치료를 위한 락토페린 기반의 유전자 전달체
JP7004968B2 (ja) * 2017-10-06 2022-01-21 青葉化成株式会社 食用の徐放性機能材の製造方法
KR102790067B1 (ko) 2017-11-03 2025-04-04 디에스엠 아이피 어셋츠 비.브이. 신규한 전달 체계
GB2571749A (en) * 2018-03-07 2019-09-11 Anabio Tech Limited A method inducing satiety in a mammal
CN110353271B (zh) * 2019-06-13 2022-07-22 陕西科技大学 一种抑制食道反流的特殊医学食品增稠组件及其制备方法
FR3102913B1 (fr) * 2019-11-07 2024-08-02 Huddle Corp Aliment ou complément alimentaire pour animaux d’élevage
US20220225650A1 (en) 2021-01-21 2022-07-21 Tropicana Products, Inc. Materials and Methods for Inhibiting Material Mixing in a Material Processing System
CN113368130B (zh) * 2021-06-25 2023-02-28 陕西科技大学 一种纤维状载铁复合物及其制备方法
US11590071B2 (en) 2021-07-06 2023-02-28 King Abdulaziz University Injectable drug delivery implant composition and method of use thereof
CN116999404B (zh) * 2023-06-21 2025-11-21 西南大学 一种分隔化多腔室铁蛋白递送体系的制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115733A (ja) * 1984-06-30 1986-01-23 Miyoshi Oil & Fat Co Ltd マイクロカプセルの製造方法
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
JP2001342127A (ja) * 2000-06-02 2001-12-11 Nomoto Kikuo 腸吸収性抗炎症因子含有免疫性物質及びその応用
JP4833553B2 (ja) * 2002-11-04 2011-12-07 オーシャン・ニュートリション・カナダ・リミテッド 複数の殻を有するマイクロカプセル及びそれらの調製方法
JP2006510359A (ja) * 2002-12-18 2006-03-30 ユニリーバー・ナームローゼ・ベンノートシヤープ 親油性コアを含む複合コアセルベートカプセル
ZA200508355B (en) * 2003-05-28 2007-03-28 Unilever Plc Satiety enhancing food products
KR20080055788A (ko) * 2005-07-07 2008-06-19 오션 뉴트리션 캐나다 리미티드 이송 장치가 구비된 식품 및 이의 제조를 위한 방법
ES2604081T3 (es) 2007-01-10 2017-03-02 Dsm Nutritional Products Ag Microcápsulas que incluyen proteína de guisante
US9332774B2 (en) * 2007-06-27 2016-05-10 Bunge Oils, Inc. Microencapsulated oil product and method of making same
US9186640B2 (en) * 2007-08-28 2015-11-17 Pepsico, Inc. Delivery and controlled release of encapsulated lipophilic nutrients
GB0811024D0 (en) * 2008-06-17 2008-07-23 E Therapeutics Plc Sustained release treatment of depression
BRPI1001091A2 (pt) * 2009-04-22 2011-03-22 Dr Suwelack Skin & Health Care Ag artigo moldado revestido secado por congelamento
US20110150995A1 (en) * 2009-12-22 2011-06-23 Hemant Narahar Joshi Solid Dosage Forms of Essential Oils
EP2625966A1 (en) * 2012-02-13 2013-08-14 Bionanoplus, S.L. Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
CN103301091B (zh) * 2012-03-12 2014-12-03 昆明制药集团股份有限公司 一种天麻素两次脉冲释药制剂
CL2012002056A1 (es) * 2012-07-24 2014-01-24 Map Chile SpA Proteina animal micrencapsulada para consumo humano que comprende particulas proteicas, y una matriz de gelatina de origen animal; y particula de proteina animal microencapsulada para consumo humano.
US10075858B2 (en) * 2012-09-20 2018-09-11 Telefonaktiebolaget L M Ericsson (Publ) Weighted RSRP measurement
WO2014078912A1 (en) * 2012-11-26 2014-05-30 Progel Pty Ltd Coating composition

Also Published As

Publication number Publication date
EP3177274A1 (en) 2017-06-14
US10052287B2 (en) 2018-08-21
WO2016020217A1 (en) 2016-02-11
CN106572979B (zh) 2021-03-12
CN106572979A (zh) 2017-04-19
US10646450B2 (en) 2020-05-12
US20170231917A1 (en) 2017-08-17
US20180325827A1 (en) 2018-11-15
JP2017532291A (ja) 2017-11-02

Similar Documents

Publication Publication Date Title
JP6660372B2 (ja) 送達システム
Lu et al. Development of emulsion gels for the delivery of functional food ingredients: From structure to functionality
Chen et al. Alginate–whey protein granular microspheres as oral delivery vehicles for bioactive compounds
Liu et al. Preparation, formation mechanism and in vitro dynamic digestion behavior of quercetin-loaded liposomes in hydrogels
Li et al. Control of lipase digestibility of emulsified lipids by encapsulation within calcium alginate beads
Corstens et al. Food-grade micro-encapsulation systems that may induce satiety via delayed lipolysis: A review
Shu et al. Effect of internal and external gelation on the physical properties, water distribution, and lycopene encapsulation properties of alginate-based emulsion gels
Sari et al. Preparation and characterization of nanoemulsion encapsulating curcumin
Celli et al. Bioactive encapsulated powders for functional foods—a review of methods and current limitations
Jimenez-Colmenero et al. Novel applications of oil-structuring methods as a strategy to improve the fat content of meat products
Gharibzahedi et al. New trends in the microencapsulation of functional fatty acid‐rich oils using transglutaminase catalyzed crosslinking
Tokle et al. Physicochemical properties of lactoferrin stabilized oil-in-water emulsions: Effects of pH, salt and heating
Bannikova et al. Microencapsulation of fish oil with alginate: In-vitro evaluation and controlled release
Guo et al. Impact of colloidal structure of gastric digesta on in-vitro intestinal digestion of whey protein emulsion gels
JP2017532291A5 (https=)
Marze Bioaccessibility of nutrients and micronutrients from dispersed food systems: impact of the multiscale bulk and interfacial structures
Wu et al. Structural stability and release properties of emulsion-alginate beads under gastrointestinal conditions
Chen et al. Controlling lipid digestion profiles using mixtures of different types of microgel: Alginate beads and carrageenan beads
Tian et al. Tailoring the oral sensation and digestive behavior of konjac glucomannan-gelatin binary hydrogel based bigel: Effects of composition and ratio
Clímaco et al. Effect of the gelling mechanism on the physical properties of bigels based on whey protein isolate
Gu et al. Modulation of lipid digestion profiles using filled egg white protein microgels
US20220280600A2 (en) Gastro-resistant microencapsulates, and uses thereof to stimulate in-vivo ileal glp-1 release in a mammal
Wooster et al. Hierarchically structured phase separated biopolymer hydrogels create tailorable delayed burst release during gastrointestinal digestion
Lin et al. Plant-based delivery systems for controlled release of hydrophilic and hydrophobic active ingredients: Pea protein-alginate bigel beads
Marze Compositional, structural, and kinetic aspects of lipid digestion and bioavailability: In vitro, in vivo, and modeling approaches

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180717

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190226

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20190523

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20190614

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191125

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20191203

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200121

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200207

R150 Certificate of patent or registration of utility model

Ref document number: 6660372

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees